Development and validation of stability indicating UPLC method for the simultaneous estimation of triamterene and hydrochlorothiazide in combined dosage forms using quality by design approach

Abstract Background According to the information gathered from the literature, no technique for UPLC of triamterene and hydrochlorothiazide employing QbD in the formulations has been published. The technique development by incorporating QbD and validating for accuracy, linearity, precision, LOQ, LOD...

Full description

Bibliographic Details
Main Authors: D. Akila Devi, P. Geetha Bhavani
Format: Article
Language:English
Published: SpringerOpen 2023-02-01
Series:Future Journal of Pharmaceutical Sciences
Subjects:
Online Access:https://doi.org/10.1186/s43094-022-00438-0
_version_ 1811171823009660928
author D. Akila Devi
P. Geetha Bhavani
author_facet D. Akila Devi
P. Geetha Bhavani
author_sort D. Akila Devi
collection DOAJ
description Abstract Background According to the information gathered from the literature, no technique for UPLC of triamterene and hydrochlorothiazide employing QbD in the formulations has been published. The technique development by incorporating QbD and validating for accuracy, linearity, precision, LOQ, LOD, ruggedness and selectivity as per ICH is part of the work’s modernity. Results Screening investigations led to the selection of cmps. Peak tailing was evaluated as a metric of technique robustness based on these important analytical attributes, namely retention time. With a 0.1 percent OPN: methanol (40:60) mobile phase, a flow rate of 0.3 ml/min, a wave length of 224 nm, an injection volume of 41, and a run time of 6 min, the best chromatographic separation was attained. Conclusions The method was verified using ICH criteria, which ensure a high level of linearity, accuracy, precision, specificity and robustness. As a result, the suggested approach is regarded as a quick and accurate method for estimating triamterene and hydrochlorothiazide at the same time.
first_indexed 2024-04-10T17:20:34Z
format Article
id doaj.art-7325093629be4133be1c878f642cf6f0
institution Directory Open Access Journal
issn 2314-7253
language English
last_indexed 2024-04-10T17:20:34Z
publishDate 2023-02-01
publisher SpringerOpen
record_format Article
series Future Journal of Pharmaceutical Sciences
spelling doaj.art-7325093629be4133be1c878f642cf6f02023-02-05T12:06:32ZengSpringerOpenFuture Journal of Pharmaceutical Sciences2314-72532023-02-019112310.1186/s43094-022-00438-0Development and validation of stability indicating UPLC method for the simultaneous estimation of triamterene and hydrochlorothiazide in combined dosage forms using quality by design approachD. Akila Devi0P. Geetha Bhavani1Department of Pharmaceutics, School of Pharmaceutical Sciences, Vels Institute of Science Technology and Advanced StudiesDepartment of Pharmaceutics, School of Pharmaceutical Sciences, Vels Institute of Science Technology and Advanced StudiesAbstract Background According to the information gathered from the literature, no technique for UPLC of triamterene and hydrochlorothiazide employing QbD in the formulations has been published. The technique development by incorporating QbD and validating for accuracy, linearity, precision, LOQ, LOD, ruggedness and selectivity as per ICH is part of the work’s modernity. Results Screening investigations led to the selection of cmps. Peak tailing was evaluated as a metric of technique robustness based on these important analytical attributes, namely retention time. With a 0.1 percent OPN: methanol (40:60) mobile phase, a flow rate of 0.3 ml/min, a wave length of 224 nm, an injection volume of 41, and a run time of 6 min, the best chromatographic separation was attained. Conclusions The method was verified using ICH criteria, which ensure a high level of linearity, accuracy, precision, specificity and robustness. As a result, the suggested approach is regarded as a quick and accurate method for estimating triamterene and hydrochlorothiazide at the same time.https://doi.org/10.1186/s43094-022-00438-0QbDUPLCOPAICH guidelinesTriamtereneHydrochlorothiazide
spellingShingle D. Akila Devi
P. Geetha Bhavani
Development and validation of stability indicating UPLC method for the simultaneous estimation of triamterene and hydrochlorothiazide in combined dosage forms using quality by design approach
Future Journal of Pharmaceutical Sciences
QbD
UPLC
OPA
ICH guidelines
Triamterene
Hydrochlorothiazide
title Development and validation of stability indicating UPLC method for the simultaneous estimation of triamterene and hydrochlorothiazide in combined dosage forms using quality by design approach
title_full Development and validation of stability indicating UPLC method for the simultaneous estimation of triamterene and hydrochlorothiazide in combined dosage forms using quality by design approach
title_fullStr Development and validation of stability indicating UPLC method for the simultaneous estimation of triamterene and hydrochlorothiazide in combined dosage forms using quality by design approach
title_full_unstemmed Development and validation of stability indicating UPLC method for the simultaneous estimation of triamterene and hydrochlorothiazide in combined dosage forms using quality by design approach
title_short Development and validation of stability indicating UPLC method for the simultaneous estimation of triamterene and hydrochlorothiazide in combined dosage forms using quality by design approach
title_sort development and validation of stability indicating uplc method for the simultaneous estimation of triamterene and hydrochlorothiazide in combined dosage forms using quality by design approach
topic QbD
UPLC
OPA
ICH guidelines
Triamterene
Hydrochlorothiazide
url https://doi.org/10.1186/s43094-022-00438-0
work_keys_str_mv AT dakiladevi developmentandvalidationofstabilityindicatinguplcmethodforthesimultaneousestimationoftriamtereneandhydrochlorothiazideincombineddosageformsusingqualitybydesignapproach
AT pgeethabhavani developmentandvalidationofstabilityindicatinguplcmethodforthesimultaneousestimationoftriamtereneandhydrochlorothiazideincombineddosageformsusingqualitybydesignapproach